Ad is loading...
BPSCX
Price
$29.34
Change
+$0.51 (+1.77%)
Updated
Nov 22 closing price
VISVX
Price
$51.30
Change
+$0.69 (+1.36%)
Updated
Nov 22 closing price
Ad is loading...

BPSCX vs VISVX

Header iconBPSCX vs VISVX Comparison
Open Charts BPSCX vs VISVXBanner chart's image
Boston Partners Small Cap Value II I
Price$29.34
Change+$0.51 (+1.77%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$51.30
Change+$0.69 (+1.36%)
VolumeN/A
CapitalizationN/A
BPSCX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BPSCX vs. VISVX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPSCX is a Buy and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. BPSCX (595M). VISVX pays higher dividends than BPSCX: VISVX (1.90) vs BPSCX (0.62). BPSCX was incepted earlier than VISVX: BPSCX (26 years) vs VISVX (27 years). BPSCX is a more actively managed with annual turnover of: 65.00 vs. VISVX (16.00). BPSCX has a lower initial minimum investment than VISVX: BPSCX (2500) vs VISVX (3000). VISVX annual gain was more profitable for investors over the last year : 30.04 vs. BPSCX (15.18). VISVX return over 5 years is better than : 62.14 vs. BPSCX (21.34).
BPSCXVISVXBPSCX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years27 years-
Gain YTD18.01117.712102%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets595M57.6B1%
Annual Yield % from dividends0.621.9033%
Returns for 1 year15.1830.0451%
Returns for 3 years-7.8916.92-47%
Returns for 5 years21.3462.1434%
Returns for 10 years37.38109.8334%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EFXT9.240.20
+2.21%
Enerflex Ltd
RVSN0.440.01
+1.60%
Rail Vision Ltd
CAG27.170.05
+0.18%
Conagra Brands
FULC2.97-0.02
-0.67%
Fulcrum Therapeutics
KYMR43.51-0.54
-1.23%
Kymera Therapeutics